| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | FA161 | 595.5516676 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 730.2018506 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 805.4028813 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 887.5306472 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 984.102537 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 1039.031482 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 1079.554904 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 1151.005906 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 3241.538462 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 3400.22945 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 3513.128983 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 3520.853333 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 3544.245792 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 3884.693167 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 4027.836103 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 5594.334591 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 9617.053501 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 10893.66037 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 11666.62069 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 11677.25611 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 13942.52302 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 14619.79333 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 15042.06731 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 18125.3607 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 18768.17579 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 18926.07289 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 19026.20598 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 19056.26859 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 22708.34129 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 24036.59487 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 28139.45842 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | 28761.96673 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA161 | intensity | Wild-type | LPS | |
| Reversed phase UNSPECIFIED ION MODE | FA161 | intensity | Wild-type | LPS+antiPla2g5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|